Core Insights - CPI Aerostructures, Inc. reported financial results for Q4 and full year 2025, highlighting challenges due to the A-10 Program termination but also significant contract wins in the Aerospace & Defense sector [3][4] - The company ended 2025 with a strong backlog of $505 million and successfully refinanced its debt, enhancing financial flexibility [5] Financial Performance - Q4 2025 revenue was $19.4 million, down from $21.8 million in Q4 2024; gross profit decreased to $3.9 million from $4.3 million, with a gross margin of 20.3% compared to 20.0% [8] - Full year 2025 revenue was $69.3 million, down from $81.1 million in 2024; gross profit fell to $10.6 million from $17.2 million, resulting in a gross margin of 15.2% [8] - Net loss for 2025 was $0.8 million compared to a net income of $3.3 million in 2024; earnings per share were ($0.07) compared to $0.26 [8] Operational Highlights - The company achieved significant milestones in support of critical defense priorities and secured new contracts from major clients including Raytheon and Lockheed Martin [4][5] - CPI Aero is recognized as a prime contractor to the U.S. Department of Defense and provides various services including engineering and program management [6] Debt and Financial Position - As of December 31, 2025, total debt was $18.4 million, an increase from $17.4 million in 2024; the company refinanced its debt with Western Alliance Bank, extending maturity to December 2030 [8][5] - Total assets increased to $75.2 million in 2025 from $68.0 million in 2024, while total liabilities rose to $49.4 million from $42.0 million [13][14]

Core Viewpoint - The Gabelli Equity Trust has updated the offering price of its Rights Offering to $5.00 per share and extended the expiration date to April 21, 2026 [1][2]. Group 1: Offering Details - The Subscription Price has been revised from $5.50 to $5.00 per share, reflecting current market conditions and investor feedback [1]. - The expiration date for the Rights Offering has been extended to April 21, 2026, at 5:00 PM Eastern Time [2]. - Ten Rights allow a shareholder to purchase one additional share of common stock, with an over-subscription privilege available for those who fully exercise their Primary Subscription Rights [3]. Group 2: Trading and Resubscription - The Rights will continue to trade on the New York Stock Exchange until April 20, 2026 [4]. - Subscriptions previously submitted through brokers will be cancelled due to the change in Subscription Price and expiration date, requiring shareholders to resubscribe at the new price [4]. Group 3: Company Overview - The Gabelli Equity Trust Inc. is a diversified, closed-end management investment company with total net assets of $2 billion, focusing on long-term capital growth [6].

Core Insights - The merger with Juniper Capital Advisors has significantly transformed PEDEVCO's scale, reserves, and earnings potential, expanding its operational footprint and nearly doubling its proved reserves [2][12]. Financial Performance Fourth Quarter 2025 - Average daily production increased by 143% to 5,310 Boe/d compared to Q4 2024 [3]. - Revenue rose by 118% to $23.1 million from $10.6 million in Q4 2024 [3][8]. - Adjusted EBITDA surged by 203% to approximately $15.4 million, up from $5.1 million in the prior year [3][21]. - The company reported a net loss of $8.5 million, a decline from a net income of $5.9 million in Q4 2024 [3][20]. Full-Year 2025 - Full-year average daily production was 2,494 Boe/d, a 36% increase from 1,835 Boe/d in 2024 [4][29]. - Total revenue for 2025 was $45.8 million, reflecting a 16% increase from $39.6 million in 2024 [4][22]. - Adjusted EBITDA for the year was $27.0 million, an 18% increase from $22.9 million in 2024 [4][28]. - The company reported a net loss of $10.4 million, compared to a net income of $12.3 million in 2024 [4][27]. Operational Highlights - The merger added approximately 310,000 net acres, significantly increasing the company's asset base in the Rockies [12]. - Year-end 2025 proved reserves totaled 32.1 million barrels of oil equivalent (MMBoe), a 77% increase from 18.1 MMBoe at year-end 2024 [12][40]. - The company participated in the drilling and completion of 36 gross development wells during 2025, with many beginning production in late 2025 [12]. Cost and Expense Analysis - Lease operating expenses (LOE) increased by 184% to $10.8 million in Q4 2025, primarily due to the acquired assets [15]. - General and administrative expenses rose by $9.8 million to $12.0 million, largely due to merger-related costs [16]. - Depreciation, depletion, amortization, and accretion (DD&A) increased by 32% to $6.8 million, driven by higher production volumes [17]. Guidance and Future Outlook - For 2026, the company anticipates net capital expenditures of $16 million to $20 million, with a focus on drilling and optimization projects [13]. - The guidance for adjusted EBITDA in 2026 is projected to be between $60 million and $70 million, based on average oil and gas prices [13][14].

Core Viewpoint - Allied Gold Corporation has received shareholder approval for its arrangement with Zijin Gold International Company Limited, marking a significant step in the company's strategic development [1]. Group 1: Shareholder Meeting Results - A total of 76,556,033 votes were cast, representing 61.14% of the total issued and outstanding Common Shares [2]. - Of the votes cast, 76,206,335 Common Shares, or 99.54%, were in favor of the Transaction [2]. - Excluding votes from interested parties, 59,621,291 Common Shares, or 99.42%, supported the Transaction [2]. Group 2: Company Overview - Allied Gold is a Canadian gold producer with a growth-oriented profile, operating three producing assets and development projects in Côte d'Ivoire, Mali, and Ethiopia [3]. - The company is led by experienced mining executives and aims to enhance its operational capabilities to become a mid-tier gold producer in Africa and a leading global gold producer [3].

Core Viewpoint - INLIF LIMITED has announced a 1-for-16 share combination of its authorized and issued ordinary shares to strengthen its long-term capital structure and maintain compliance with Nasdaq's listing requirements [1][5]. Group 1: Share Combination Details - The authorized share capital will be US$350,000, divided into 209,375,000 Class A ordinary shares and 9,375,000 Class B ordinary shares, each with a par value of US$0.0016 [2]. - The share combination will take effect on April 6, 2026, at 09:30 a.m. Eastern Time, with Class A ordinary shares continuing to trade on Nasdaq under the symbol "INLF" [3]. - Following the share combination, the number of Class A ordinary shares will be reduced to 13,025,000 and Class B ordinary shares to 781,250 [4]. Group 2: Company Overview - INLIF LIMITED, through its subsidiary Ewatt Robot Equipment Co. Ltd., is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms [6]. - The company offers installation and warranty services for manipulator arms, along with accessories and raw materials, producing a diverse portfolio of manipulator arms [6].

Core Viewpoint - Aptose Biosciences Inc. is advancing its clinical-stage precision oncology efforts with a focus on a tuspetinib (TUS)-based triple drug therapy for newly diagnosed acute myeloid leukemia (AML), following shareholder approval for a significant acquisition by Hanmi Pharmaceutical [1][2][5]. Corporate Update - Shareholders approved the transition of Aptose from the Canada Business Corporations Act to the Business Corporations Act (Alberta) and the acquisition plan by Hanmi Pharmaceutical, which will acquire all outstanding common shares not owned by Hanmi [3]. - Hanmi has provided over US$41 million in financial support to Aptose over the past two years, facilitating the development of the TUS+VEN+AZA therapy [3][5]. - Under the acquisition terms, Aptose shareholders will receive C$2.41 per common share, representing a 28% premium over the 30-day volume-weighted average price (VWAP) of C$1.88 [3]. Voting Results - A total of 1,164,030 common shares were voted at the special meeting, with 92.42% voting in favor of the continuance resolution and 91.48% in favor of the arrangement resolution [4]. - Among shares voted by non-Hanmi affiliates, 84.87% supported the arrangement resolution [4]. Clinical Data Highlights - The TUS+VEN+AZA triplet therapy has shown promising safety and efficacy in newly diagnosed AML patients, achieving high rates of minimal residual disease (MRD)-negative remissions across diverse mutations [5][8]. - At the 160 mg dose level, early findings indicate patients achieving MRD-negativity and formal responses within the first few weeks of treatment [9]. Financial Results - For the year ended December 31, 2025, Aptose reported total operating expenses of $24.7 million, a decrease from $26.3 million in 2024 [12]. - The net loss for 2025 was $25.5 million, slightly higher than the $25.4 million loss in 2024 [12]. - Research and development expenses decreased to $11.3 million in 2025 from $15.1 million in 2024, primarily due to reduced activities in the APTIVATE clinical trial [17][19]. Balance Sheet Overview - As of December 31, 2025, Aptose had cash and cash equivalents of $4.1 million, down from $6.7 million in 2024 [14]. - The company reported a working capital deficit of $2.86 million and total assets of $10 million [14].

Core Insights - High Arctic Energy Services Inc. reported significant financial and operational progress in 2025, with increased customer activity particularly in central Alberta, driven by developments in the Duvernay region [3][16] - The company remains optimistic for 2026, as key customers have increased their spending plans, indicating a positive outlook for future operations [5][16] Financial Performance - Revenue from continuing operations for FY 2025 was $10,641 thousand, an increase of $171 thousand compared to FY 2024 [6][18] - Adjusted EBITDA for FY 2025 was $2,007 thousand, representing 19% of revenue and a 90% increase from FY 2024 [6][18] - Net income for FY 2025 was $356 thousand, a significant improvement from a net loss of $2,117 thousand in FY 2024 [18][6] - The oilfield services operating margin increased to 48.9% in FY 2025 from 47.8% in FY 2024, reflecting improved operational efficiency [6][18] Operational Highlights - High Arctic maintained a strong safety record, completing 2025 without any recordable incidents, marking six consecutive years of zero Total Recordable Incident Frequency Rate (TRIF) [8][16] - The company achieved a reduction in general and administrative expenses by 34% compared to FY 2024, enhancing overall financial performance [6][8] Strategic Objectives - The strategic objectives for 2026 include growing core businesses through selective investments, managing costs effectively, and seeking accretive acquisitions to drive shareholder value [8][16] - High Arctic invested $1,233 thousand in capital expenditures in 2025, primarily focused on growth in the high-margin rental equipment business [8][16] Team Snubbing Investment - High Arctic holds a 42% equity interest in Team Snubbing, which reported a net income of $882 thousand for FY 2025, a turnaround from a net loss of $690 thousand in FY 2024 [6][31] - Team Snubbing's improved performance is attributed to increased activity levels in Alaska and a recovery in Canadian operations [32][31] Market Outlook - Despite ongoing economic uncertainties, the energy supply-demand dynamics remain resilient, with cautious optimism for supportive commodity pricing in the medium to long term [19][21] - The Canadian energy industry is poised for growth, supported by recent infrastructure developments and a federal mandate to enhance Canada's position as a global energy superpower [21][19]

Company Overview - AirSculpt Technologies, Inc. is an industry leader in premium body contouring procedures, focusing on next-generation treatments that optimize comfort and precision [3]. Financial Results Announcement - AirSculpt will report its fourth quarter and fiscal year 2025 financial results on April 2, 2026, before market open, followed by a conference call at 8:30 a.m. Eastern Time [1]. Conference Call Details - The conference call can be accessed via a toll-free domestic number or an international number, using the conference ID 13758597, and a live webcast will be available on the company's investor relations website [2].

Core Insights - Allied Gold Corporation reported solid operational and financial results for Q4 2025, producing 117,004 ounces of gold, exceeding annual guidance and demonstrating strong momentum heading into 2026 [1][4][12] - The company achieved an All-in Sustaining Cost (AISC) of $1,980 per ounce, reflecting a 5% reduction from the previous quarter, driven by increased production and operational improvements [4][30] Financial Results Highlights - The fourth quarter net loss was $23.6 million or $(0.19) per share, while adjusted earnings were $69.0 million or $0.56 per share [4] - Net cash generated from operating activities for the quarter was $189.3 million, with EBITDA of $138.6 million and adjusted EBITDA of $204.6 million [4][12] - As of December 31, 2025, the company had cash and cash equivalents of $479.8 million [4] Operational Highlights - Total gold production for 2025 reached 379,081 ounces, surpassing the annual production guidance of 375,000 ounces [4][12] - Fourth quarter production represented a 34% increase over the average production of the previous three quarters, marking the highest quarterly production to date [4][12] - Performance by asset included 57,191 ounces from Sadiola, 33,279 ounces from Bonikro, and 26,534 ounces from Agbaou, with all operations showing improved performance [4][12][45] Growth Initiatives - The company entered into a definitive agreement with Zijin Gold for the acquisition of Allied Gold at a price of C$44 per share, representing a significant premium to the market price [7][9] - Key growth projects include the completion of the Sadiola Phase 1 grinding circuit expansion and ongoing construction at the Kurmuk Project, expected to commence operations in mid-2026 [8][59] - Exploration efforts in 2025 included 40,503 meters of drilling across multiple project areas, aimed at maintaining and increasing mineral resources [8][40] Cost Management - AISC margins improved significantly, increasing from $1,370 per ounce in Q3 to approximately $2,160 per ounce in Q4, reflecting higher realized gold prices [4][5] - The company expects AISC for 2026 to be between $1,945 and $2,160 per ounce, based on a gold price assumption of $4,250 per ounce [20] Sustainability and Safety - The company reported no significant environmental incidents for the year ended December 31, 2025, with a Total Recordable Injury Rate of 1.21 [13]

Core Insights - Del Taco is celebrating National Burrito Day by offering a free Classic Burrito with a minimum purchase of $3 for Del Yeah! Rewards members on April 2, 2026 [1][2][3] Company Overview - Del Taco is the second-largest Mexican quick service restaurant in the United States, recognized for its unique variety of Mexican and American favorites, including burritos and fries [1][5][6] - The company serves over three million guests weekly at nearly 600 locations across 17 states, emphasizing fresh ingredients and made-to-order meals [6][7] Marketing Strategy - The promotion aims to enhance customer engagement and loyalty through the Del Yeah! Rewards program, which allows members to access exclusive deals [2][3] - The Chief Marketing Officer highlighted the importance of creating memorable experiences for customers during promotional events [2] Offer Details - The free burrito offer is limited to one per guest and requires registration in the Del Yeah! Rewards program, with redemption available through the Del Taco app or website [3][4] - The offer is not valid with other promotions or third-party delivery services, ensuring exclusivity for rewards members [3]